We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

BETA THALASSEMIA (B THAL) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 - 2028)

Beta-thalassemia (B-thal) Market, by Treatment (Iron Chelating Drugs, Erythroid Maturation Agents, Stem Cell Therapy, and Others), by Disease Indication (Beta Thalassemia Minor, Beta Thalassemia Intermedia, and Beta Thalassemia Major), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In: 26 Nov, 2021
Code: CMI4793
Page number: 192
Formats: Excel and PDF
Industry: Pharmaceutical

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Treatment
  - Market Snippet, By Disease Indication
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Reimbursement Scenario
- Mergers & Acquisitions
Global Beta-thalassemia (B-thal) Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
Global Beta-thalassemia (B-thal) Market, By Treatment, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Iron Chelating Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Erythroid Maturation Agents
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Stem Cell Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Global Beta-thalassemia (B-thal) Market, By Disease Indication, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Beta Thalassemia Minor
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Beta Thalassemia Intermedia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Beta Thalassemia Major
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Global Beta-thalassemia (B-thal) Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, By Region, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018–2028
- North America
  - Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
    - U.S.
    - Canada
- Latin America
  - Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Market Size and Forecast, By Treatment, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Disease Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, By Region/Country, 2017 – 2028, (US$ Mn)
    - South Africa
    - Central Africa
    - North Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
  - Celgene Corp.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - BlueBird Bio
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Protagonist Therapeutics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Agios Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Ionis Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Vifor Pharma
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Orchard Therapeutics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Sangamo Therapeutics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - CRISPR Therapeutics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - DisperSol Technologies
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Kiadis Pharma
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Incyte Corporation
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Editas Medicine
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Global Blood Therapeutics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Syros Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 38 market data tables and 31 figures on "Beta-thalassemia (B-thal) Market” - Global forecast to 2028

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now